Latest Brain Tumor News and Research
BTTC 11-02 and 09-01 Clinical Trial Results Get Presented at ASCO
June 15, 2015
BTTC investigators presented results from two BTTC clinical trials during the poster presentations at the recent meeting of the American Society of Clinical Oncology in May, 2015. Dr. Raizer was asked to present the results of the BTTC 09-01 trial and Dr. Puduvalli presented the results of the BTTC 11-02 trial.
BTTC Investigators Publish Paper in Neuro-Oncology Journal
January 20, 2015
The Brain Tumor Trials Collaborative investigators publish the BTTC factorial phase II study results in the February 2015 issue of the Neuro-Oncology Journal.
2014 Holiday Newsletter from Head for the Cure
December 2, 2014
A letter from the Head for the Cure Foundation. Funds raised by the HFTC Foundation provides funding for the Brain Tumor Trials Collaborative.
The Annual BTTC Meeting
February 21, 2014
In the seventh year, it is easy to see the expansion of the BTTC. There are currently seven clinical trials either open or in development.
BTTC on Houston Radio Station
October 13, 2013
Dr. Mark Gilbert and Terri Armstrong, Ph.D. were interviewed on Houston P.A. in October, 2013. They spoke about the BTTC, Head for the Cure, the advances in brain tumor research as well as what led them to their career paths.
BTTC 08-01 Clinical Trial Results Get Presented at ASCO
July 8, 2013
Dr. Raizer was asked to present the results of the BTTC 08-01 clinical trial at the recent meeting of the American Society of Clinical Oncology in June, 2013.
The Annual BTTC Meeting
February 28, 2013
Over 80 members discussed the expanding portfolio of BTTC studies (9 either open or in the pipeline). The BTTC is a growing network with the expertise and the desire to participate in state-of-the-art clinical trials investigating new treatments for malignant brain tumors.
2012 Holiday Newsletter from Head for the Cure
December 10, 2012
Milestones of 2012 from the Head for the Cure Foundation (HFTC). They continue on a quest to defeat brain cancer step by step.
First BTTC Clinical Trial Results Presented
November 9, 2012
Three BTTC Clinical Trials Open For EnrollmentSeptember 27, 2012
Vimpat vs. Placebo Study: This study’s primary objective is to determine if prophylactic administration of lacosamide reduces the risk of seizures in patients with a high-grade glioma. Newly diagnosed, post-operative patients are tested during the first year after tumor diagnosis.
BTTC and HFTC Featured on Fox 4 NewsSeptember 1, 2012
Local news coverage from the annual Metro KC Head for the Cure 5K race held on August 26, 2012. Matt Anthony, President of HFTC and Dr. Mark Gilbert, Principal Investigator for BTTC, are interviewed by Fox 4 News.
Others Make a Difference
August 25, 2011
Others create awareness and generate funds for HFTC and brain cancer research.